Skip to main content
Bioscience of Microbiota, Food and Health logoLink to Bioscience of Microbiota, Food and Health
. 2021 Feb 10;40(2):123–134. doi: 10.12938/bmfh.2020-038

A cross-sectional analysis from the Mykinso Cohort Study: establishing reference ranges for Japanese gut microbial indices

Satoshi WATANABE 1,*, Shoichiro KAMEOKA 1, Natsuko O SHINOZAKI 1, Ryuichi KUBO 1, Akifumi NISHIDA 1,2,3, Minoru KURIYAMA 1, Aya K TAKEDA 1
PMCID: PMC8099632  PMID: 33996369

Abstract

The purpose of this study was to establish reference ranges for gut microbial indices by collecting real-world Japanese microbiome data from a Mykinso cohort. Although several large cohort studies have focused on the human gut microbiome, large cohort studies of the gut microbiome from Japanese populations are scarce, especially from healthy or non-diseased individuals. We collected stool samples and original survey lifestyle information from 5,843 Japanese individuals through the Mykinso gut microbiome testing service. From the obtained 16S rRNA sequence data derived from stool samples, the ratio and distribution of each taxon were analyzed. The relationship between different epidemiological attributes and gut microbial indicators were statistically analyzed. The qualitative and quantitative indicators of these common gut microbiota were confirmed to be strongly correlated with age, sex, constipation/diarrhea, and history of lifestyle-related diseases. Therefore, we set up a healthy sub-cohort that controlled for these attribute factors and defined reference ranges from the distribution of gut microbial index in that population. Taken together, these results show that the gut microbiota of Japanese people had high beta-diversity, with no single “typical” gut microbiota type. We believe that the reference ranges for the gut microbial indices obtained in this study can be new reference values for determining the balance and health of the gut microbiota of an individual. In the future, it is necessary to clarify the clinical validity of these reference values by comparing them with a clinical disease cohort.

Keywords: gut microbiota, 16S rRNA, Japanese, reference range, microbial index

INTRODUCTION

Since the establishment of next-generation 16S rRNA sequencing analysis, multiple large cohort studies focusing on the human gut microbiome have been conducted, such as the US Human Microbiome Project [1] and MetaHIT in Europe [2]. An integrated catalog of human fecal microbial metagenomes from 1,200 people in the United States, China, and Europe has identified 9.9 million microbial genes across fecal microbiota [3]. However, studies on gut microbiome from Japanese populations are scarce, especially those reporting on healthy or non-diseased individuals. Further, in recent studies comparing gut microbiomes by race/nationality, clear impacts of dietary habits were demonstrated [4], suggesting that, owing to the unique Japanese food culture, the gut of Japanese individuals could harbor different flora from those of individuals in western countries. Therefore, to advance research on the gut microbiome and various diseases in Japan, it is critical to characterize the healthy gut microbiome in the Japanese population.

Host parameters such as age, gender, and body mass index (BMI) have been reported to be related to individual differences in gut microbiota composition [5,6,7,8,9]. Further, differences in dietary habits have been shown to affect the bacterial diversity and enterotype of human gut microbiota [10, 11], which may partially explain why differences in residential areas/countries are strongly associated with differences in gut microbiota composition [12, 13].

Recently, several studies have revealed gender differences in gut microbiota [14,15,16,17]. For instance, Min et al. [18] conducted an association study to identify bacterial compositions associated with men and women, and showed similar microbiota characteristics, including overall abundance and diversity, between men and women. However, they also showed gender differences at the species level between microbial taxa related to fat distribution, suggesting the existence of a gender-specific microbiome signature corresponding to gender-specific fat distribution, which may also contribute to the observed sex-specific immunity differences [19]. Thus, several immune pathophysiologies may be involved in gender differences in gut bacterial composition.

Age is also an important factor affecting the gut microbiota [8, 20,21,22,23]. Recent reports have described differences in gut microbiota between children and adults, and an adult-like composition of bacterial communities is established at around 3–4 years of age or older [7, 20, 24,25,26]. In addition, the intestinal microbiota has been shown to change with age, although the definition of old age has differed between reports and include individuals older than 60, 65, 70, or 100 years [14, 27,28,29]. The associated mechanism also remains unknown. Yatsunenko et al. [8] conducted a large study of subjects aged 0–83 years and showed continuous changes that occurred with age. They found that the period required to form an adult-like gut microbiota was the 3-year period following birth. Second, interpersonal variation was significantly greater between children than between adults. Third, the dominance of Bifidobacterium in the baby microbiota continued throughout the first year of life, although this dominance diminished with age. Nevertheless, owing to the limited number of subjects over 60 years of age, the specific continuous changes that occur in older people remain unknown. Recently, Odamaki et al. [7] reported age-related compositional differences from infants to centenarians in a Japanese cross-sectional study. They found that Bifidobacterium decreased and Enterobacteriaceae increased with age, as observed in some previous studies [8, 21,22,23].

Relationships have also been observed between gut microbiota and diarrhea/constipation. Vandeputte et al. [30] described an association between stool consistency and gut microbiota composition in 53 healthy female subjects. Tigchelaar et al. [31] also reported an association between stool consistency and the structure of gut microbiota. Hadizadeh et al. [32] demonstrated a correlation between the number of bowel movements and gut microbiota. In a Japanese cohort, Takagi et al. [33] reported significant differences in microbial structure between individuals with differences in stool consistency (Bristol stool scale type). Therefore, investigating the relationship between bowel habits and intestinal bacterial composition can provide important information on gastrointestinal motility function.

However, Japan has its own food culture and customs compared to western countries, and the intestinal flora of Japanese individuals contain more genes for polysaccharide-degrading enzymes derived from water-soluble dietary fiber than Americans [34]. This feature may be related to the longer life expectancy of Japanese people and their low BMIs [35, 36]. Nishijima et al. [37] clearly showed significant differences in the gut microbiota of the Japanese population compared to other countries, which cannot be explained by meals alone. Therefore, the structure of the intestinal flora may be highly dependent on an individual’s country/region and lifestyle [38].

In this study, we investigated the relative abundance ranges of microbial taxa in stool samples from a large healthy human cohort. Further, we analyzed the relationship between the aforementioned genera or gut microbiota composition and Japanese demographic features, lifestyle, and bowel habits. Finally, we developed reference ranges using a large healthy Japanese cohort and considered the effects of age, gender, diarrhea, and constipation.

MATERIALS AND METHODS

Study design and participants

From November 2015 through June 2019, a Mykinso cohort of 5,843 individuals who had submitted fecal samples (one sample per subject) was selected from data obtained through the Mykinso gut microbiome testing service. Informed consent was obtained from all participants in the study. All procedures complied with the principles of the Declaration of Helsinki and were approved by the Institutional Review Board (IRB) at our institution, and the study was registered as UMIN000028887 and UMIN000028888 in the UMIN Clinical Trials Registry System. The IRB-approved protocol specifically allows for a study involving a cross-sectional (one time per subject) analysis of the survey data and subsequent follow-up survey (multiple times per subject). In this study, we analyzed only cross-sectional data from the cohort study dataset.

Demographic features, bowel habits, and disease and medication data

Using an original survey (Supplementary Table 1), metadata were collected through the Mykinso gut microbiome testing service. The original survey included questions on demographic features, lifestyle, bowel habits, and disease. Individuals were scored positive for a disease if they replied yes to any original survey question, negative if they replied no, and unknown if data were unavailable across all original surveys.

Fecal sampling, DNA extraction, and sequencing

Fecal samples were collected using brush-type collection kits containing guanidine thiocyanate solution (Techno Suruga Laboratory, Shizuoka, Japan), transported at normal temperature, and stored at 4°C. DNA extraction from the fecal samples was performed using an automated DNA extraction system (GENE PREP STAR PI-480, Kurabo Industries Ltd, Osaka, Japan) according to the manufacturer’s protocol. The V1–V2 region of the 16S rRNA gene was amplified using a forward primer (16S_27Fmod: TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG AGR GTT TGA TYM TGG CTC AG) and a reverse primer (16S_338R: GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GTG CTG CCT CCC GTA GGA GT) and KAPA HiFi HotStart ReadyMix (Roche). To sequence 16S amplicons by Illumina MiSeq platform, dual index adapters were attached using the Nextera XT Index kit. Each library was diluted to 5 ng/µL, and equal volumes of the libraries were mixed to 4 nM. The DNA concentration of the mixed libraries was quantified by qPCR with KAPA SYBR FAST qPCR Master Mix (KK4601, KAPA Biosystems) using primer 1 (AAT GAT ACG GCG ACC ACC) and primer 2 (CAA GCA GAA GAC GGC ATA CGA). The library preparations were carried out according to 16S library preparation protocol of Illumina (Illumina, San Diego, CA, USA). Libraries were sequenced using the MiSeq Reagent Kit v2 (500 Cycles), to produce 250 bp paired-end reads.

Taxonomy assignment based on 16S rRNA gene sequences

Paired-end reads of partial 16S rRNA gene sequences were clustered by 97% nucleotide identity and then assigned taxonomic information using the Greengenes database (v13.8) [39] through the QIIME pipeline (v1.8.0) [40]. The steps for data processing and assignment based on the QIIME pipeline were as follows: (i) joining paired-end reads; (ii) quality filtering with an accuracy of Q30 (>99.9%) and a read length > 300 bp; (iii) randomly extracting 10,000 reads per sample for subsequent analysis; (iv) clustering operational taxonomic units (OTUs) with 97% identity by UCLUST (v1.2.22q) [41]; and (v) assigning taxonomic information to each OTU using the RDP classifier [42] with the full-length 16S gene data of Greengenes (v13.8) to determine the identity and composition of bacterial genera.

Transformation of compositional microbiome data for hypothesis testing

Centered log-ratio (clr) transformed values were used as inputs for multivariate hypothesis testing [43] to manage 0 count values as both point estimates using the zCompositions R package [44] and as a probability distribution using the ALDEx2 package [45] available on Bioconductor.

Group differences in beta-diversity

Aitchison distance, the Euclidian distance between samples after clr transformation, and the distances between samples are the same as the phylogenetic ilr [43]. Replacement for β-diversity exploration of microbiome data is a variance-based compositional principal component (PCA) biplot [46], in which the relationship between inter-OTU variance and sample distance can be observed [47]. Compositional PCA biplots display the relationships between OTUs and distances between samples on a common plot to glean substantial and qualitative information regarding dataset quality and the relationships between groups [47].

Group differences in alpha-diversity

Microbiota diversity was assessed by the Shannon index based on 97% nucleotide sequence identity. These values were calculated using QIIME [40] with a depth of 10,000 reads. To test two-group differences between male and female groups, we calculated p values using the two-sided unpaired Welch’s t-test. To test group differences among age groups in the diversity index, we calculated p values using one-way analysis of variance (ANOVA).

Group differences in taxonomic abundance

To compare the taxonomic abundance between the groups, we conducted the univariate statistical test using the ALDEx2 tool. The false discovery rate (FDR) control was performed based on the Benjamini-Hochberg procedure to correct for multiple testing, i.e., ‘p.adjust’ in R. Analysis was confined to taxa with a prevalence greater than 10% and a maximum proportion (relative abundance) greater than 0.005. An FDR-adjusted p-value less than 5% was considered to be significant.

RESULTS

Cohort characteristics

The participants primarily resided in Japan (n=5,843; Supplementary Table 2) and were characterized by a greater range in age, stool type, and lifestyle than the participants in other Japanese large-scale microbiome projects [7, 33, 37]. In the original survey, participants (n=4,479) reported demographic features, disease history, and lifestyle data (participants missing any of these data were excluded; Supplementary Table 3). In accordance with our IRB, all survey questions were optional (question response rate, 76.65%). Eligible subjects were male and female who were considered to not have disease history (ineligible subjects were those who self-reported any disease history; Supplementary Table 4). Eligible criteria included no self-reported history of any disease. Ultimately, 2,865 individuals were included in the subsequent analysis (Table 1, Supplementary Fig. 1).

Table 1. Distribution of primary eligible subjects.

Demographicfeatures Female Male
Number of samples 1,722 1,143
BMI 21.1 (3.0) 23.1 (3.5)
Age 40.16 (11.30) 41.77 (11.30)
Age group
19 and under 20 (1.2%) 10 (0.9%)
20–29 322 (18.7%) 135 (11.8%)
30–39 559 (32.5%) 408 (35.7%)
40–49 485 (28.2%) 358 (31.3%)
50–59 249 (14.5%) 159 (13.9%)
60–69 73 (4.2%) 52 (4.5%)
70 and over 14 (0.8%) 21 (1.8%)

Mean (SD); n/N (%).

BMI: Body Mass Index.

Sex-related gut microbiota

Taxonomic differences in microbial communities were evaluated at the genus level. The comparison of microbial composition between male and female subjects showed a significant richness in the abundances of 12 and 13 genera in male and female subjects, respectively (blue and red points, respectively, in Fig. 1). The results were characterized by a richness in the representative genera Prevotella, Megamonas, Collinsella, Dorea, Megasphaera, and Fusobacterium (p<0.001, FDR-adjusted p-value<0.005) in male subjects and an increase in representative genera Oscillospira, Coprobacillus, Ruminococcus, Bacteroides, Eggerthella, Anaerotruncus, Trabulsiella, and Akkermansia (p<0.001, FDR-adjusted p-value <0.005) in female subjects. Subsequently, we evaluated the alpha-diversity of gut microbiota using the Shannon index. The Shannon index showed no statistically significant differences between male (mean=6.013) and female (mean=6.008) subjects (Welch’s two-sample t-test; t (2,352.5) =−0.198, p=0.843, 95% CI =−0.049 to 0.060). Next, the dissimilarity of the overall structure of the gut microbiome for male and female subjects, beta-diversity was calculated using Aitchison distance (Fig. 2). PCA revealed that there were structural differences between male and female subjects (PERMANOVA, R2=0.060, p=0.001).

Fig. 1.

Fig. 1.

Relative abundances of gut microbiota in male and female subjects. Genera were significantly different between male and female subjects. diff_btw = median difference in clr values between female and male groups. magenta: positive diff_btw in female group; cyan: negative diff_btw in female group.

Fig. 2.

Fig. 2.

Plot of individual samples from PCA output (magenta: female samples, cyan: male samples). The distance between points is proportional to the Euclidian distance of CLR vectors of the samples (Aitchison distance). The multivariate distance between samples was estimated using the Aitchison distance, which showed significantly different composition between female and male samples (ANOSIM, R2=0.060, p=0.001).

Age-related gut microbiota

Further, differences in the gut microbial structure in each age group were taxonomically evaluated at the phylum level (Fig. 3). In agreement with previous results, the microbiota composition included four predominant phyla (Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria). Of these, Actinobacteria showed a trend to decrease in the 60 years old group (p=0.040, FDR-adjusted p-value=0.640) and 70 years or older group (p=0.048, FDR-adjusted p-value=0.700), compared to the 19 years or under group. The alpha-diversity index showed significant differences across age groups in our cohort (ANOVA; F(6,2851) = 5.045, p<0.001; Fig. 4). We also tested the multiplicity correction of each pair difference with the Benjamini & Hochberg method, and statistically significant differences were found between 20s and 60s age groups (p<0.001), between 30s and 60s age groups (p=0.008), between 20s and 40s age group (p=0.006), and between 50s and 60s age groups (p=0.043;Table 2). Additionally, we created three age groups (young group, 0–19; adult group, 20–59; and elderly group, 60 years or older), and the overall structure of the gut microbiome using beta-diversity indices was calculated using Aitchison distance (Fig. 5). PCA revealed that there were microbial structural differences among the three age groups (PERMANOVA, R2=0.034, p<0.001).

Fig. 3.

Fig. 3.

Comparative analyses of the taxonomic composition of the microbial community at the phylum level for each age group. Each component of the cumulative bar chart indicates a phylum.

Fig. 4.

Fig. 4.

Age-related differences in the Shannon index of gut microbiota.

Table 2. Pairwise comparisons of the Shannon index between age groups.

Age-group pair diff lwr upr p.adj
20s–19under 0.001 −0.398 0.400 1.000
30s–19under 0.109 −0.284 0.502 0.983
30s–20s 0.108 −0.012 0.228 0.112
40s–19under 0.151 −0.242 0.545 0.917
40s–20s 0.151 0.027 0.274 0.006
40s–30s 0.043 −0.057 0.142 0.870
50s–19under 0.128 −0.272 0.529 0.965
50s–20s 0.127 −0.017 0.272 0.125
50s–30s 0.019 −0.106 0.145 0.999
50s–40s −0.023 −0.151 0.105 0.998
60s–19under 0.349 −0.082 0.779 0.203
60s–20s 0.348 0.134 0.562 <0.001
60s–30s 0.240 0.039 0.441 0.008
60s–40s 0.197 −0.006 0.400 0.063
60s–50s 0.220 0.004 0.437 0.043
70over–19under 0.303 −0.224 0.830 0.618
70over–20s 0.302 −0.069 0.674 0.199
70over–30s 0.194 −0.170 0.559 0.701
70over–40s 0.152 −0.214 0.517 0.885
70over–50s 0.175 −0.198 0.548 0.812
70over–60s −0.046 −0.451 0.359 1.000

diff: Differences in mean levels; lwr: 95% confidence lower level; upr: 95% confidence upper level

p.adj: p-value adjusted by Benjamin & Hochberg medhods.

Fig. 5.

Fig. 5.

(a) Plot of individual samples from PCA output (red: elderly samples, blue: young samples, and gray: adult samples). The distance between points is proportional to the Euclidian distance of CLR vectors of the samples (Aitchison distance). (b) The multivariate distance between samples was estimated using the Aitchison distance, which showed significantly different compositions in the junior, adult and senior samples (red: elderly r, blue: young, and gray: adult) (PERMANOVA, R2=0.034, p<0.001).

Bowel habits-related gut microbiota

Considering the heterogeneity and varying generations of samples in this dataset, we excluded samples from the young (0–19) and elderly (60 years or older) groups, which might have caused bias in the subsequent analysis [7, 14, 27,28,29]. As a result, 2,675 samples were included in the resulting dataset (Table 3, Supplementary Fig. 1). The bowel habits (stool shape and defecation frequency) of all participants enrolled in this study were recorded and classified using the self-reported original survey. Additionally, perceived symptoms of diarrhea/constipation were recorded and classified. According to the stool shape, bowel frequency, and perceived symptom scores, participants were classified as normal bowel habit type, diarrhea type, constipation type, or mixed type. Participants reporting stool type 1 (hard stool), defecation frequency type 4 (less than once per week), or frequent perception of constipation symptoms within 1 month were classified into the constipation type. Participants reporting stool type 7 (liquid stools), defecation frequency type 1 (more than three times per day), or frequent perception of diarrhea symptoms within 1 month were classified as the diarrhea type. Finally participants who fit into both the constipation and the diarrhea types were classified into the mixed type. The constipation group (female, n=337, 20.87%; male, n=37, 3.49%), diarrhea group (female, n=357, 22.11%; male, n=457, 43.11%), mixed group (female, n=139, 8.61%; male, n=29, 2.74%), and normal group (female, n=782, 48.42%; male, n=537, 50.66%) were observed (Table 3). Importantly, the Shannon index for each bowel habit group showed a significant difference among groups in our cohort (ANOVA; F(3,2667)=1.761, p<0.001; Fig. 6). We also tested each pair difference with the Benjamini & Hochberg method, which showed statistically significant differences between the normal and diarrhea groups (p<0.001), constipation and diarrhea groups (p<0.001), and mixed and diarrhea groups (p=0.001). These differences are illustrated in Fig. 6. Additionally, the beta-diversity indices among the four bowel habit groups using was calculated using Aitchison distance and visualized by PCA according to Aitchison distance (Fig. 7). An additional PERMANOVA analysis showed that the bowel habit type was a significant factor contributing to the variation of the structure of the gut microbiota (p<0.001). Approximately 0.7% of the variance in beta-diversity was explained by the bowel habit type (PERMANOVA; F(3,2667)=6.714, R2=0.007, p<0.001), which was competitive with available measurements for clinical and environmental covariates. Subsequently, at the genus level, we identified several altered bacteria among the four bowel habit groups. Interestingly, a significantly higher relative abundances of Fusobacterium (p<0.001, FDR-adjusted p-value<0.005) and Oscillospira (p<0.001, FDR-adjusted p-value<0.005) were observed in the diarrhea and constipation groups, respectively. In addition, the relative abundances of Ruminococcus, Anaerotruncus, Alistipes, and Akkermansia (p<0.01, FDR-adjusted p-value<0.05) were significantly higher in the constipation group, whereas that of Dorea (p<0.01, FDR-adjusted p-value<0.05) was higher in the diarrhea group.

Table 3. Distribution of bowel habits by sex and age group (20–50).

Age-group: gender Normal stool Diarrhea Constipation Mixed Number of samples
20–29: male 59 69 2 5 135
20–29: female 149 76 57 40 322
30–39: male 196 185 14 13 408
30–39: female 243 134 128 54 559
40–49: male 185 150 15 8 358
40–49: female 233 112 111 29 485
50–59: male 97 53 6 3 159
50–59: female 157 35 41 16 249
Sum 1,319 814 374 168 2,675

Fig. 6.

Fig. 6.

Alteration of the Shannon index of gut microbiota associated with stool consistency. Comparison of α-diversity indices: Shannon index (OTU evenness estimation). Bowel habit was categorized into four groups: normal, diarrhea, constipation, and mixed.

Fig. 7.

Fig. 7.

(a) Plot of individual samples from PCA output (gray: normal samples, red: diarrhea samples, green: constipation samples, and blue: mixed type samples). The distance between points is proportional to the Euclidian distance of CLR vectors of the samples (Aitchison distance). The multivariate distance between samples was estimated using the Aitchison distance, which showed significantly different compositions between the bowel habit type (PERMANOVA, R2=0.007, p<0.001). (b) RDA triplot of CLR vectors of the samples constrained by bowel habit group.

Reference ranges from the healthy Japanese cohort

Considering the heterogeneity and bowel habits of the sample dataset, we excluded samples from individuals with diarrhea or constipation (Supplementary Fig. 1), which might cause bias in reference ranges [30,31,32,33]. Ultimately, 1,319 samples were selected as a healthy reference dataset (Supplementary Fig. 1). We identified 453 genera and 20 phyla of Bacteria and Archaea in the gut microbiomes of the healthy reference dataset. The genera with an average relative abundance of ≥ 0.5% in the Japanese healthy reference dataset are listed in Supplementary Fig. 2. At the genus level, the Japanese healthy reference was characterized by the highest abundances of Bacteroides, Faecalibacterium, Prevotella, Blautia, Bifidobacterium, Coprococcus, and Parabacteroides (Supplementary Fig. 2).

In this study, health-related microbiome indices were selected based on peer-reviewed studies in academic journals and in-house data analyses (Table 4). To determine the reference ranges of 11 target microbiome indices, the dataset of 1,319 individuals selected from the Mykinso cohort as described above was established. Microbiome data from this dataset were analyzed to determine the empirical reference ranges for two indices of overall community structure, two complex genus indices, one class, and six genera. For each of the 1,319 samples, we determined the relative abundance of each target within the microbial population, revealing the distribution of the relative abundance of each target in the cohort (Table 4). These data were used to define a central 80% healthy range with confidence intervals for each target. Many of the targets show significant spread, highlighting the importance of defining reference ranges for health-related indices.

Table 4. Reference ranges from healthy Japanese subjects for 11 clinically relevant indices.

Microbiome Index unit group lower limit[10%] median [50%] upper limit [90%] Reference
Shannon value all 5.08 6.01 6.88 [58, 59]
male 5.15 6.03 6.93
female 5.05 6 6.85

Observed genera genus all 54 65 80 [58, 59]
male 54 65 81
female 54 66 79

Bifidobacterium % all 0.18 2.47 9.6 [60, 61]
male 0.12 2.18 8.45
female 0.21 2.79 10.41

Faecalibacterium % all 0.55 6.83 12.87 [62]
male 0.37 6.36 12.09
female 0.57 7.23 13.27

Butyric acid-producing genera group *1 % all 4.25 12.16 20.47 [59]
male 3.64 11.53 20.03
female 4.66 12.88 20.89

Clostridium % all 0 0.19 0.79 [59]
male 0 0.19 0.7
female 0 0.2 0.89

Lactobacillales genera group verified lactic acid producers *2 % all 0 0.01 0.22 [59, 63]
male 0 0.01 0.24
female 0 0.01 0.21

Streptococcus % all 0.05 0.38 2.58 [63, 65]
male 0.03 0.34 2.46
female 0.05 0.41 2.65

Genera group popular in oral cavity *3 % all 0.18 1.4 9.74 [63, 65]
male 0.15 1.31 9.71
female 0.2 1.48 9.9

Fusobacterium % all 0 0 1.37 [59, 64]
male 0 0 2.92
female 0 0 0.83

Observed genera within class Gammaproteobacteria class all 2 5 8 [59, 65]
male 2 5 8
female 2 5 8

*1: This index included Coprococcus, Roseburia, Butyricicoccus, Faecalibacterium, Anaerostipes, and Butyricimonas.

*2: This index included Lactobacillus, Pediococcus, Leuconostoc, Lactococcus, and Weissella.

*3: This index included Streptococcus, Fusobacterium, and Enterobacter genera.

DISCUSSION

We developed reference ranges using a large healthy Japanese cohort. The reference ranges consider the effect of age, gender, diarrhea, and constipation to aid physicians with accurate diagnosis of the intestinal bacterial composition ratio using a standard value derived from a healthy population. Eighteen intestinal bacterial indicators suggested to be associated with health status were selected. Using intestinal bacterial composition test panels, the detection of intestinal bacterial indicators outside of their healthy ranges can be useful evidence to support a medical plan.

Gut microbiota and sex/gender

Some characteristics of gender-specific immune differences are induced by gut microbiota. Fransen et al. [48] investigated significant gender differences in bacterial groups at the family or genus level. Females had higher abundances of Desulfovibrionaceae, Lactobacillaceae (Lactobacillus at the genus level), and Verrucomicrobiaceae (Akkermansia at the genus level), whereas males had higher abundances of Ruminococcaceae and Rikenellaceae (Alistipes at the genus level). In this study, several characteristic differences were observed between male and female subjects regarding the abundances of gut microbiota at the genus level. The genera Prevotella, Megamonas, Fusobacterium, and Megasphaera were significantly abundant in male subjects, whereas Bifidobacterium, Ruminococcus, and Akkermansia were significantly abundant in female subjects. These results are consistent with the results of previous Japanese studies [7, 33] and may be considered as the characteristic gender differences in the composition of intestinal microbiota in the Japanese population.

Gut microbiota and age/generation

Recent reports have shown a clear difference in the composition of the intestinal microbiota of infants, adults, and the elderly [7, 8, 33]. The microbiota composition initially shifts after birth, followed by significant shifts during childhood and in later years [20]. In this study, we segmented the population by age group (young, adult, and elderly group). Our results are in agreement with studies indicating clear differences in gut microbiota composition among infants, adults, and the elderly [7, 49, 50]. It was found that the Actinobacteria abundance and alpha-diversity index were gut microbiome indices related to aging. The most dramatic changes in gut microbiota diversity occur in early childhood [20], but recent large cross-sectional cohort studies have also reported increases in adulthood [7, 51]. In our cross-sectional cohort, the alpha-diversity index showed slight increasing trend from 20 to 69 years old (Fig. 4) that was consistent with recent previous reports [7, 51]. On the other hand, other recent studies have suggested that both Bacteroides abundance and species diversity decline in the feces of elderly subjects and that the abundance of Bifidobacterium is reduced [27]. The gut microbiota composition of elderly subjects is expected to be in a state of flux [20]. In our cross-sectional cohort, most elderly individuals were community dwellers not in long-term residential care; this state of healthy aging may maintain a high diversity of gut microbiota.

Gut microbiota and bowel habits (diarrhea/constipation)

Similarly to Vandeputte et al. [30], we found a significant association between bowel habits (stool shape and defecation frequency) and gut microbiota diversity. Furthermore, deviations of the gut microbiota composition in several genera, including Oscillospira, Ruminococcus, Anaerotruncus, Alistipes, and Akkermansia, in constipation subjects and Fusobacterium and Dorea in diarrhea subjects were confirmed, which is consistent with a previous report [33]. Although the role of these genera in stool consistency remains unclear, the results illustrate the effect of gut microbiota on stool consistency in healthy Japanese subjects.

Gut microbiota and racial/regional differences

Our results showed that Japanese adults (20–59 years old) had a greater abundance of the genera Bacteroides and Faecalibacterium, interquartile ranges (IQRs) of 27.43% (19.03–35.26) and 6.83% (3.39–10.06), respectively, and a relatively lower abundance of the genera Clostridium (IQR 0.20%, 0.04–0.44), compared with previous studies in other Japanese cohorts [37]. However, the estimated abundances of Bifidobacterium and Blautia were greater (IQRs of 2.47% (0.86–5.78), and 5.31% (2.94–7.85), respectively) than those of a previous study in other nations (<0.5% and >5%, in the US and China, respectively) [37]. These bacterial compositions may be characteristic of the intestinal microbiota of the Japanese population but may also reflect differences in DNA extraction methods [52, 53] and the amplified region of the 16S rRNA [54].

A high abundance of Bifidobacterium has also been observed in the gut microbiome of Japanese children by 16S rRNA gene analysis [12], indicating its high prevalence throughout the Japanese population. Bifidobacterium is thought to be a beneficial microbe that contains more glycoside hydrolases for degrading starch than other intestinal microbes [55, 56]. Therefore, the high abundance of Bifidobacterium may be a consequence of the intake of various saccharides in traditional and unique Japanese foods. However, it is unknown which foods or nutrients contribute to the high abundance of Bifidobacterium. As future prospects, it is essential to create a reference microbiota for the Japanese population by age group and to increase the number of subjects in the young and the elderly age groups. Additionally, investigations of geographical differences within Japan are of interest.

Clinical relevance and reference ranges

All 11 microbiome indices successfully identified using 16S rRNA gene sequencing were associated with specific health conditions. Alpha-diversity, including the Shannon index, and observed genera number appeared to be associated with better health [57]. A recent meta-analysis proposed reduced alpha-diversity as a reliable indicator of diarrhea-associated dysbiosis [58]. These microbiota diversity indices (Shannon index and observed OTUs) revealed significant differences in the healthy aging group, indicating that a healthy, diverse diet promotes greater diversity in the gut microbiota [57].

Previous studies have proposed that Bifidobacterium is inversely associated with inflammatory bowel disease (IBD) and diarrhea-associated dysbiosis [59] and the consumption of probiotics, inulin, and oligofructoses promotes an increase in Bifidobacterium abundance [60]. Additionally, Faecalibacterium has been proposed to be a dominant member of the human intestinal microbiota in healthy adults and especially to be a health sensor for active Crohn’s disease patients [61]. A recent meta-analysis showed a reduction in butyrate-producing Clostridiales, including Coprococcus, Roseburia, Butyricicoccus, Faecalibacterium, Anaerostipes, and Butyricimonas, which are associated with a healthy gut [59].

Although not all genera within the order Lactobacillales are verified lactic acid producers, the dominant genera within this order (including Lactobacillus, Pediococcus, Leuconostoc, Lactococcus, and Weissella) are known to harbor genes for lactic acid production and are often enriched in the case of patients across multiple diseases [58]. Lactobacillales genera have been shown to adapt to the lower pH of the upper gastrointestinal tract [62]. Thus, the shared disease-associated taxa may be indicators of shorter stool transit times and disruptions in the redox state and/or pH of the lower intestine, rather than specific pathogens. Genera within Lactobacillaceae and Streptococcaceae families are dominant in the upper gastrointestinal tract and are present in the stool of many individuals at low frequency [58]. These taxa likely become enriched with faster stool transit time (i.e., a diarrhea signature) [58].

Previous studies have proposed Fusobacterium to be associated with various human diseases [63]. Dysbiosis associated with colorectal cancer is generally characterized by increased prevalence of known pathogenic or pathogen-associated Fusobacterium and Enterobacter genera, which were shown to be higher in colorectal cancer patients in two or more studies [58]. Furthermore, other oral community genera, such as members of Porphyromonas, Peptostreptococcus, and Parvimonas, were found with Fusobacterium on colonic tumors [64].

Limitations

We concede that this study has several limitations. First, this research was a participatory observational study. This kind of study may be self-selecting and have a tendency for illness behaviors, which may create a biased cohort rather than a true representation of the Japanese population [65]. As shown in Supplementary Table 1, the study cohort contained mostly females in their 30s and 40s, followed by males in their 30s and 40s. In addition, as shown in Table 3, in the cohort of the adult (20–59) age group, 50% or more of individuals in the group answered that they had diarrhea or constipation, a higher prevalence than in the general Japanese population. On the other hand, we believe that it was possible to adjust for these biases by screening the analysis dataset as shown in Supplementary Fig. 1. We excluded individuals with a medical history, the elderly, the young, and those with diarrhea/constipation symptoms to extract the reference value population. We did not exclude obese individuals from our reference dataset because Japan has one of the lowest rates of prevalence of obesity (about 4–4.5% of the adult population) in the world [66], and the obese population (BMI >30) in our healthy reference dataset was even lower (3.8% for men, 3.5% for women). Therefore, we believe they did not make a strong impact on the reference range values. However, it might be better to reconsider adding the BMI criterion for a more rigorous definition of “healthy” in future studies. Second, the scope of the present study did not extend to analysis of the influence of medication such as antibiotics on the gut microbiota profile, thus representing a qualitative limitation.

CONCLUSION

Regardless of health status, there are many microorganisms that are clinically related to health and disease in the intestines of all people, and the exquisite balance of these microorganisms varies greatly from person to person, making the definition of “good flora” difficult. However, to understand and monitor the health and balance of an individual’s gut microbiota, it is essential to first know the reference ranges available from a large, healthy population such as the one presented here. By further expanding the cohort of healthy subjects and accumulating a cohort of various health conditions and attributes, more valuable indicators can be identified, leading to the realization of personalized precision medicine using microbiome information in the future.

DATA AVAILABILITY

Requests for materials and/or data should be addressed to the corresponding author, SW.

Supplementary Material

Supplement figure
bmfh-40-123-s001.pdf (267KB, pdf)

Acknowledgments

We thank Dr. Shota Nakamura (Osaka University), the iMet Laboratory team (Osaka University), and Biken Biomics, Inc. for sequencing and technical support and thank Dr. Takeaki Uno (National Institute of Informatics) for support with data analysis. We also would like to thank Editage (www.editage.com) for English language editing. Finallyt, we would like to express our deepest gratitude to all the participants of the Mykinso cohort who provided valuable data for our research.

REFERENCES

  • 1.Human Microbiome Project Consortium2012. A framework for human microbiome research. Nature 486: 215–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J, MetaHIT Consortium2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, Juncker AS, Manichanh C, Chen B, Zhang W, Levenez F, Wang J, Xu X, Xiao L, Liang S, Zhang D, Zhang Z, Chen W, Zhao H, Al-Aama JY, Edris S, Yang H, Wang J, Hansen T, Nielsen HB, Brunak S, Kristiansen K, Guarner F, Pedersen O, Doré J, Ehrlich SD, Bork P, Wang J, MetaHIT ConsortiumMetaHIT Consortium2014. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32: 834–841. [DOI] [PubMed] [Google Scholar]
  • 4.Lynch SV, Pedersen O. 2016. The human intestinal microbiome in health and disease. N Engl J Med 375: 2369–2379. [DOI] [PubMed] [Google Scholar]
  • 5.Flak MB, Neves JF, Blumberg RS. 2013. Immunology. Welcome to the microgenderome. Science 339: 1044–1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. 2014. Human genetics shape the gut microbiome. Cell 159: 789–799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ, Abe F, Osawa R. 2016. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16: 90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. 2012. Human gut microbiome viewed across age and geography. Nature 486: 222–227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang J, Guo Z, Lim AAQ, Zheng Y, Koh EY, Ho D, Qiao J, Huo D, Hou Q, Huang W, Wang L, Javzandulam C, Narangerel C, Jirimutu, Menghebilige, Lee YK, Zhang H. 2014. Mongolians core gut microbiota and its correlation with seasonal dietary changes. Sci Rep 4: 5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107: 14691–14696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nakayama J, Watanabe K, Jiang J, Matsuda K, Chao SH, Haryono P, La-Ongkham O, Sarwoko MA, Sujaya IN, Zhao L, Chen KT, Chen YP, Chiu HH, Hidaka T, Huang NX, Kiyohara C, Kurakawa T, Sakamoto N, Sonomoto K, Tashiro K, Tsuji H, Chen MJ, Leelavatcharamas V, Liao CC, Nitisinprasert S, Rahayu ES, Ren FZ, Tsai YC, Lee YK. 2015. Diversity in gut bacterial community of school-age children in Asia. Sci Rep 5: 8397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.La-Ongkham O, Nakphaichit M, Leelavatcharamas V, Keawsompong S, Nitisinprasert S. 2015. Distinct gut microbiota of healthy children from two different geographic regions of Thailand. Arch Microbiol 197: 561–573. [DOI] [PubMed] [Google Scholar]
  • 14.Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJF, Doré J, Blaut M. 2006. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72: 1027–1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, Quintana-Navarro GM, Landa BB, Navas-Cortés JA, Tena-Sempere M, Clemente JC, López-Miranda J, Pérez-Jiménez F, Camargo A. 2016. Intestinal microbiota is influenced by gender and body mass index. PLoS One 11: e0154090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, Antonopoulos D, Umesaki Y, Chervonsky AV. 2013. Gender bias in autoimmunity is influenced by microbiota. Immunity 39: 400–412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339: 1084–1088. [DOI] [PubMed] [Google Scholar]
  • 18.Min Y, Ma X, Sankaran K, Ru Y, Chen L, Baiocchi M, Zhu S. 2019. Sex-specific association between gut microbiome and fat distribution. Nat Commun 10: 2408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mitsuoka T. 2014. Establishment of intestinal bacteriology. Biosci Microbiota Food Health 33: 99–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA, Weersma RK, Feskens EJ, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J, LifeLines cohort study2016. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352: 565–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D’hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu J, Henckaerts L, Zhernakova A, Wijmenga C, Raes J. 2016. Population-level analysis of gut microbiome variation. Science 352: 560–564. [DOI] [PubMed] [Google Scholar]
  • 23.Maurice CF, Haiser HJ, Turnbaugh PJ. 2013. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152: 39–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Avershina E, Storrø O, Øien T, Johnsen R, Pope P, Rudi K. 2014. Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol Ecol 87: 280–290. [DOI] [PubMed] [Google Scholar]
  • 25.Bergström A, Skov TH, Bahl MI, Roager HM, Christensen LB, Ejlerskov KT, Mølgaard C, Michaelsen KF, Licht TR. 2014. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 80: 2889–2900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cheng J, Ringel-Kulka T, Heikamp-de Jong I, Ringel Y, Carroll I, de Vos WM, Salojärvi J, Satokari R. 2016. Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J 10: 1002–1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O’Connor M, Harnedy N, O’Connor K, Henry C, O’Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O’Toole PW. 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108Suppl 1: 4586–4591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mariat D, Firmesse O, Levenez F, Guimarăes V, Sokol H, Doré J, Corthier G, Furet JP. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9: 123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C, Brigidi P, De Vos W. 2010. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5: e10667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. 2016. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65: 57–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tigchelaar EF, Bonder MJ, Jankipersadsing SA, Fu J, Wijmenga C, Zhernakova A. 2016. Gut microbiota composition associated with stool consistency. Gut 65: 540–542. [DOI] [PubMed] [Google Scholar]
  • 32.Hadizadeh F, Walter S, Belheouane M, Bonfiglio F, Heinsen FA, Andreasson A, Agreus L, Engstrand L, Baines JF, Rafter J, Franke A, D’Amato M. 2017. Stool frequency is associated with gut microbiota composition. Gut 66: 559–560. [DOI] [PubMed] [Google Scholar]
  • 33.Takagi T, Naito Y, Inoue R, Kashiwagi S, Uchiyama K, Mizushima K, Tsuchiya S, Dohi O, Yoshida N, Kamada K, Ishikawa T, Handa O, Konishi H, Okuda K, Tsujimoto Y, Ohnogi H, Itoh Y. 2019. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol 54: 53–63. [DOI] [PubMed] [Google Scholar]
  • 34.Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464: 908–912. [DOI] [PubMed] [Google Scholar]
  • 35..World Health Organization. 2015. Global Health Observatory (GHO) data: overweight and obesity.
  • 36.Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, Takami H, Morita H, Sharma VK, Srivastava TP, Taylor TD, Noguchi H, Mori H, Ogura Y, Ehrlich DS, Itoh K, Takagi T, Sakaki Y, Hayashi T, Hattori M. 2007. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14: 169–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, Hattori M. 2016. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 23: 125–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M’rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P, Bork P, MetaHIT Consortium2011. Enterotypes of the human gut microbiome. Nature 473: 174–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72: 5069–5072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460–2461. [DOI] [PubMed] [Google Scholar]
  • 42.Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. 2009. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141–D145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Aitchison J, Barcelo-Vidal C, Martın-Fernandez JA, Pawlowsky-Glahn V. 2000. Logratio analysis and compositional distance. Math Geol 32: 271–275. [Google Scholar]
  • 44.Palarea-Albaladejo J, Martín-Fernández JA. 2015. zCompositions—R package for multivariate imputation of left-censored data under a compositional approach. Chemom Intell Lab Syst 143: 85–96. [Google Scholar]
  • 45.Gloor GB, Reid G. 2016. Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data. Can J Microbiol 62: 692–703. [DOI] [PubMed] [Google Scholar]
  • 46.Aitchison J, Greenacre M. 2002. Biplots of compositional data. J Royal Stat Soc C 51: 375–392(Applied Statistics). [Google Scholar]
  • 47.Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. 2017. Microbiome datasets are compositional: and this is not optional. Front Microbiol 8: 2224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Fransen F, van Beek AA, Borghuis T, Meijer B, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HF, de Jonge MI, Faas MM, Boekschoten MV, Smidt H, El Aidy S, de Vos P. 2017. The impact of gut microbiota on gender-specific differences in immunity. Front Immunol 8: 754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Conlon MA, Bird AR. 2014. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7: 17–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Vernocchi P, Del Chierico F, Putignani L. 2016. Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol 7: 1144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.de la Cuesta-Zuluaga J, Kelley ST, Chen Y, Escobar JS, Mueller NT, Ley RE, McDonald D, Huang S, Swafford AD, Knight R, Thackray VG. 2019. Age- and sex-dependent patterns of gut microbial diversity in human adults. mSystems 4: e00261–e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wesolowska-Andersen A, Bahl MI, Carvalho V, Kristiansen K, Sicheritz-Pontén T, Gupta R, Licht TR. 2014. Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis. Microbiome 2: 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wagner Mackenzie B, Waite DW, Taylor MW. 2015. Evaluating variation in human gut microbiota profiles due to DNA extraction method and inter-subject differences. Front Microbiol 6: 130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Campbell JH, Foster CM, Vishnivetskaya T, Campbell AG, Yang ZK, Wymore A, Palumbo AV, Chesler EJ, Podar M. 2012. Host genetic and environmental effects on mouse intestinal microbiota. ISME J 6: 2033–2044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lee JH, O’Sullivan DJ. 2010. Genomic insights into bifidobacteria. Microbiol Mol Biol Rev 74: 378–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Liu S, Ren F, Zhao L, Jiang L, Hao Y, Jin J, Zhang M, Guo H, Lei X, Sun E, Liu H. 2015. Starch and starch hydrolysates are favorable carbon sources for bifidobacteria in the human gut. BMC Microbiol 15: 54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, Harnedy N, O’Connor K, O’Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O’Toole PW. 2012. Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178–184. [DOI] [PubMed] [Google Scholar]
  • 58.Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. 2017. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun 8: 1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S. 2011. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60: 631–637. [DOI] [PubMed] [Google Scholar]
  • 60.Meyer D, Stasse-Wolthuis M. 2009. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 63: 1277–1289. [DOI] [PubMed] [Google Scholar]
  • 61.Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. 2013. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 16: 255–261. [DOI] [PubMed] [Google Scholar]
  • 62.Donaldson GP, Lee SM, Mazmanian SK. 2016. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14: 20–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Han YW. 2015. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol 23: 141–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Flynn KJ, Baxter NT, Schloss PD. 2016. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere 1: e00102-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Debelius JW, Vázquez-Baeza Y, McDonald D, Xu Z, Wolfe E, Knight R. 2016. Turning participatory microbiome research into usable data: lessons from the American Gut Project. J Microbiol Biol Educ 17: 46–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.NCD Risk Factor Collaboration.2017. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies with 128.9 million children, adolescents, and adults. Lancet 390: 2627–2642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement figure
bmfh-40-123-s001.pdf (267KB, pdf)

Data Availability Statement

Requests for materials and/or data should be addressed to the corresponding author, SW.


Articles from Bioscience of Microbiota, Food and Health are provided here courtesy of IPEC, Inc.

RESOURCES